SYDNEY SIGLER: Open Payments
NPI 1043602089 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 16 payments from 6 companies in 2025. Trend: 2023 $693 · 2024 $553 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $160 |
| PFIZER INC. | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Amgen Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
Products named: Yeztugo, NURTEC ODT, KRYSTEXXA, UBRELVY, BREZTRI, Jornay PM, VYNDAQEL.
Industry payments across MO — which companies pay providers there.
